The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...

Without a doubt, everything looks promising: a surge in investments in digitalization and Artificial Intelligence (AI), ...

Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...

GLP-1 medications, on average, can cost individuals $1,000 per month if their employers do not provide insurance coverage, Andrea Grande, a principal at Brown & Brown, said ...

The controversy over Apeel’s invisible food coating is dividing shoppers and sparking questions about transparency, organic ...

Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

Clearance by the Food and Drug Administration means a Stewartville manufacturer can now sell its fecal incontinence devices in the US, after years of being limited to the European market. "It is a ...

Quarterly net revenues of $159 million, up 6% year-over-year, with 4,331 active patients on therapy as of June 30, 2025 Results from Phase 3 PANOVA-3 clinical trial presented at 2025 ASCO Annual ...

Our data show 5.6 billion people now live in regions where Aedes mosquitoes can transmit chikungunya, and 2025 outbreaks in ...